Buscar
01/09/2025
Monitoring Patients with Relapsing-Remitting Multiple Sclerosis Switching from Intravenous to Subcutaneous Natalizumab every 4 Weeks vs every 6 Weeks
Moreno, AA, Presas-Rodríguez, S, Gonzalez-Garcia, AM, Teniente-Sera, A, Martínez-Cáceres, EM, Querol, L, Martín-Aguilar, L, Meca-Lallana, JE, Dos Santos, CE, Millán, J, López, GV, Orgaz, ATC, Ruiz, VC, Anunciación, BAJ, Hervas, JV, Ruiz, LB, Bravo, GCA, Ramo, C. Monitoring Patients with Relapsing-Remitting Multiple Sclerosis Switching from Intravenous to Subcutaneous Natalizumab every 4 Weeks vs every 6 Weeks. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
Cracking the code: genotype-phenotype correlation models in sarcoglycanopathies
Luce, L, Kocak, G, Alonso-Pérez, J, Straub,, Töpf, A, Díaz-Manera, J. Cracking the code: genotype-phenotype correlation models in sarcoglycanopathies. NEUROMUSCULAR DISORDERS. 2025; 53DOI:. PMID:. IF:2.800(Q2/5D).
01/09/2025
Sustained Clinical Efficacy and Long-Term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT
Unoje, O, Hussain, Y, Habib, A, Claeys, K, Gwathmey, K, Sahagian, G, Cortés-Vicente, E, Liu, L, Jimenez, R, Patel, M, Masschaele, D, Mantegazza, R, Meisel, A, Seth, A, Attarian, S. Sustained Clinical Efficacy and Long-Term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT. ANNALS OF NEUROLOGY. 2025; 98DOI:. PMID:. IF:7.700(Q1/1D).
01/09/2025
HOW TO PROMOTE HEALTHY AND EQUITABLE RELATIONSHIPS IN FORMAL EDUCATION: THEORETICAL FRAMEWORK AND EDUCATIONAL PROPOSAL
Forcadell-Díez, L, Pérez, G, Fernández, A, Puig-Barrachina, V, Subirats, IG, Cortés, E, Moral, PD, Juárez, O. HOW TO PROMOTE HEALTHY AND EQUITABLE RELATIONSHIPS IN FORMAL EDUCATION: THEORETICAL FRAMEWORK AND EDUCATIONAL PROPOSAL. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025
Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia
Bioque, M, Llorca-Bofi, V, MacDowell, KS, Amoretti, S, Mezquida, G, Cuesta, MJ, Diaz-Caneja, CM, Ibáñez, A, Segarra, R, González-Pinto, A, Roldán, A, Sáiz, PA, Mané, A, Lobo, A, Martínez-Pinteño, A, Cano-Escalera, G, Berrocoso, E, Bernardo, M. Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia. SCHIZOPHRENIA BULLETIN. 2025; 51(5)DOI:10.1093/schbul/sbaf012. PMID:39977257. IF:4.800(Q1/2D).
01/09/2025
MPOX IN PEOPLE WITH HIV AND PREP USERS DURING THE 2022 OUTBREAK, SPAIN
March-Yagüe, A, Toledo, D, Díaz, A, Godoy, P, Pérez-Martinez, O, Pericas, C, Sánchez-Migallón, A, Domínguez, A. MPOX IN PEOPLE WITH HIV AND PREP USERS DURING THE 2022 OUTBREAK, SPAIN. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025
PERSONALIZATION OF COLORECTAL CANCER SCREENING BASED ON PREVIOUS NEGATIVE TESTS: HOW MANY TESTS SHOULD BE USED?
Velasco, AES, Serrano, MC, Barrufet, C, Augè, JM, Torà, I, Puig, T, Milà, MA, Serra, MS, Pust, AB. PERSONALIZATION OF COLORECTAL CANCER SCREENING BASED ON PREVIOUS NEGATIVE TESTS: HOW MANY TESTS SHOULD BE USED?. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025
SOCIAL DETERMINANTS OF PROXIMITY-BASED SCHOOLING AND ACTIVE SCHOOL MOBILITY IN ADOLESCENTS IN THE CITY OF BARCELONA
Amengual-Moreno, M, Oliveras, L, Marí-Dell'Olmo, M, Sánchez-Ledesma, E, Cano, GS, Font-Ribera, L. SOCIAL DETERMINANTS OF PROXIMITY-BASED SCHOOLING AND ACTIVE SCHOOL MOBILITY IN ADOLESCENTS IN THE CITY OF BARCELONA. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).